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Hematopoietic stem cells (HSCs) are thought to divide infrequently based on their resistance to cytotoxic injury targeted at rapidly cycling cells 1,2 and have been presumed to retain labels such as the thymidine analog 5-bromodeoxyuridine (BrdU). However, BrdU retention is neither a sensitive nor specific marker for HSCs 3 . Here we show that transient, transgenic expression of a histone 2B (H2B)-green fluorescent protein (GFP) fusion protein in mice has several advantages for label-retention studies over BrdU, including rapid induction of H2B-GFP in virtually all HSCs, higher labeling intensity and the ability to prospectively study label-retaining cells, which together permit a more precise analysis of division history. Mathematical modeling of H2B-GFP dilution in HSCs, identified with a stringent marker combination (L -K + S + CD48 -CD150 + ) 4 , revealed unexpected heterogeneity in their proliferation rates and showed that ~20% of HSCs divide at an extremely low rate (≤0.8-1.8% per day).
The hypothesis that stem cells cycle relatively slowly predicts that they might be identified by labels that are diluted with division, such as BrdU 5,6 , tritiated thymidine 7 or H2B-GFP 8, 9 . Indeed, label-retaining cells in the skin are enriched for epithelial stem cells 9 . Label-retaining cells in the intestine 10 , mammary gland 11 , heart 12 and bone marrow 5, 6 have also been proposed as candidate stem cell populations. However, recent observations indicated that BrdU retention is neither a sensitive nor specific marker for HSCs 3 and intestinal stem cells 13 , unsettling the widely held notion that label retention is a general property of stem cells. One major limitation of using BrdU to study label retention is that the presumed slow turnover of stem cells may prevent these cells not only from losing label with time, but also from incorporating label. In addition, it is not possible to test the function of cells prospectively isolated based on their BrdU content. To circumvent these problems, we generated a mouse strain that allows for ubiquitous, doxycyclineinducible expression of an H2B-GFP fusion protein ( Supplementary  Fig. 1a-d online) . To explore the utility of this strain for marking HSCs, we induced a large cohort of mice with doxycycline for 6 weeks (pulse; starting at 4-8 weeks of age) and monitored loss of fluorescence in the bone marrow (chase). As intended, fluorescence levels exceeding the background by several orders of magnitude were observed immediately after the pulse. In agreement with the expectation that most bone marrow cells turn over rapidly, >95% of the cells lost H2B-GFP expression after only 4 weeks of chase, and <1% expressed significant levels of H2B-GFP after 6 months or more (6 months: 0.58%, s.d. 0.46, n = 6; 1 year: 0.39%, s.d. 0.05, n = 2; 1.5 years: 0.31%, s.d. 0.1, n = 3). These frequencies of label-retaining cells were 1-2 orders of magnitude higher than the known frequencies of HSCs 4, 14 , and the majority of these cells expressed markers of mature lymphoid (T-cell lineage: CD3, CD4, CD8, TCRβ; B-cell lineage: CD19, B220) or myeloid lineages (Gr1, Mac1, Ter119) (data not shown). Thus, similar to recent findings showing that BrdU retention does not specifically identify HSCs 3 , H2B-GFP retention is not specific for HSCs when used as a single parameter.
Next, we analyzed H2B-GFP expression in combination with wellestablished surface markers for progenitors and HSCs, including lineage markers (L), c-Kit (K), Sca-1 (S), CD48 and CD150 (ref. 4) ( Fig. 1a) , and compared proliferation rates of defined populations ( Fig. 1b) with retention of H2B-GFP over time ( Fig. 1c) . Notably, all HSC/progenitor populations were quantitatively labeled immediately following the pulse ( Fig. 1c , second row '0'). Actively cycling myeloid progenitors (L -K + S -; Fig. 1a , middle panel, left frame, blue; Fig. 1b , left panel) lost the majority of H2B-GFP as soon as 2 weeks after the pulse and became entirely negative after ~8 weeks ( Fig. 1c , left column). In contrast, a population enriched for HSCs (L -K + S + ; Fig. 1a , middle panel, right frame, red), distinguished from progenitors by expression of Sca-1, cycled less actively ( Fig. 1b , second panel from the left) and lost H2B-GFP much less rapidly ( Fig. 1c ; second column from left). Within the L -K + S + population, absence of CD48 and presence of CD150 expression predict long-term repopulation potential 4 , and both of these traits also predicted increased label retention. CD48negative L -K + S + cells cycled less often than CD48-positive L -K + S + cells ( Fig. 1b , four right panels) and also lost H2B-GFP more slowly than CD48-positive L -K + S + cells ( Fig. 1c , two middle and two right columns). CD150 expression was not associated with obvious differences in cycling rates within the CD48-negative L -K + S + population ( Fig. 1b , two right panels), but label retention was nevertheless slightly, but chase 3 . We confirmed by transplantation assays that long-term repopulation potential was strictly limited to L -K + S + CD48 -CD150 + cells and demonstrated that L -K + S + CD48 -CD150cells possessed considerable short-term repopulation potential (Supplementary Figs. 2 and 3 online) 4, 15, 16 . We speculate that the subtle nature of the difference in H2B-GFP retention between L -K + S + CD48 -CD150cells and L -K + S + CD48 -CD150 + cells reflects the fact that short-term HSCs are consistently, more pronounced in CD150-positive L -K + S + CD48cells ( Fig. 1c , two right columns).
Notably, ~20% of L -K + S + CD48 -CD150 + -defined HSCs retained H2B-GFP after 24 weeks, and ~5% of HSCs retained H2B-GFP after 72 weeks of chase ( Fig. 1c, : small gray number); difference between L -K + Scells (blue box) and L -K + S + cells (red box) is significant (P = 0.005); difference between L -K + S + CD48 -CD150 + cells (yellow box) and L -K + S + CD48 -CD150cells (second from right) is not significant (P = 0.15); difference between L -K + S + CD48 -CD150 + cells (yellow box) and either of the CD48 + populations (two middle panels) is significant (P < 0.001). (c) expression of H2B-GFP in immuno-phenotypically defined early hematopoietic populations over time. In each column, analyses of a defined population (order as in b) are shown without pulse (first row), immediately after the pulse (second row), or at defined time points after the pulse (designated on the left in weeks (w), rows 3-9). Individual plots are representative histograms of H2B-GFP intensity on a logarithmic scale (x-axis covers 5 orders of magnitude). Large black numbers on individual plots show proportions (%) of H2B-GFP-positive cells above the arbitrary threshold. When multiple mice were analyzed, means are given and s.d. are shown in smaller gray numbers (number of mice (n) per time point is shown on the right of the figure). Plots in first row show that H2B-GFP background (BG) is elevated in uninduced transgenic mice (black line, n = 7, aged 2 to 15 months) as compared with wildtype (WT) mice (gray shaded area); arbitrary threshold was set above background as shown. Note: H2B-GFP is lost within 8-12 weeks in progenitors (L -K + S -; first column from left, blue box) and is retained the most in highly purified hematopoietic stem cells (L -S + K + CD48 -CD150 + ; first column from right, yellow box).
turnover in the absence of Gfi-1 and rule out the possibility that subpopulations of Gfi-1 −/− HSCs might be excluded from enhanced proliferation. Thus, we have shown that analysis of H2B-GFP retention can refine the understanding of turnover of stem cells and progenitors in mutant mice. To assess the kinetics of L -S + K + CD48 -CD150 + -defined HSC turnover, we generated mathematical models ( Fig. 3) . These models are based on three assumptions: (i) that HSCs distribute H2B-GFP equally to daughter cells (as shown in Supplementary Fig. 8 online) ; (ii) that the number of divisions necessary to dilute H2B-GFP from the levels at the end of the pulse to levels below the arbitrary threshold is unknown (although we estimated that it took ~7-8 divisions to fall below the threshold, which corresponds to ~2 logs on the GFP intensity scale (Fig. 1c) , because we cannot exclude nonproliferation-associated losses direct progeny of long-term HSCs and preserve their low-proliferative state until they differentiate further into CD48 + cells.
Similar to Signaling Lymphocyte Activation Molecule (SLAM) family markers CD48 and CD150, a number of other markers have been used to enrich for long-term repopulating HSCs within the L -K + S + population, including CD34 (ref. 14) , endothelial protein C receptor (EPCR, CD201) 17 , endoglin (CD105) 18 and Flt3 (CD135) 19 . We found that all of these markers also enrich for H2B-GFP-retaining cells, albeit to varying degrees ( Supplementary Fig. 4 online) . Thus, our data establish a correlation between a history of low proliferation and markers for long-term repopulation potential in early hematopoietic cells. Our findings do not support a recent claim that the majority of HSCs (L -K + S + Flt3 -) resides in a quiescent 'reserved' state without repopulation activity after transplantation (unless activated ex vivo) and that these cells outnumber 'primed' HSCs, which possess repopulation activity, by about fivefold 20 . If such a 'reserved' state existed, an inverse correlation between label retention and markers predicting long-term repopulation potential within the L -K + S + population should be expected, contrary to our findings. More directly, we did not observe any correlation between H2B-GFP retention and staining with the N-cadherin antibody MNCD-2, proposed to identify 'reserved' L -K + S + Flt3 -HSCs 20 Numerous molecular regulators have recently been implicated in restricting the proliferation of HSCs based on assessing cell cycle distribution or short-term BrdU incorporation assays (for review see ref. 21 ). Short-term BrdU-incorporation assays are biased toward faster-proliferating cells, and analysis of cell cycle distribution using DNA and/or RNA stains may be flawed due to superposition of heterogeneous subpopulations. In our system, mutations that increase the turnover rate of HSCs should reduce H2B-GFP retention. We did not observe accelerated loss of H2B-GFP in the HSCs of p21 Cip1/Waf1 knockout mice ( Fig. 2a) , in contrast to a previous study that used less specific methods and markers 22 . However, our data are consistent with a study that observed an impact of p21 Cip1/Waf1 loss on HSCs only in stress conditions but not in steady state 23 . Moreover, very pure HSCs (L -K + S + CD34 -) express the cyclin-dependent kinase inhibitor p57 KIP2 but not p21 Cip1/Waf1 (ref. 24 ). Together, these findings raise doubts on the widely held view that p21 Cip1/Waf1 is a key regulator of quiescence in HSCs. We did observe a drastic acceleration of H2B-GFP loss in HSCs in Gfi-1 knockout mice (Fig. 2b) , confirming and extending previous investigations using BrdU 25, 26 . As the method described here initially labels all cells regardless of cell-cycle stage, our data unequivocally demonstrate that all lineage marker-negative cells undergo faster HSCs is associated with functional differences, we prospectively isolated and transplanted L -K + S + CD48 -CD150 + cells that had retained different levels of H2B-GFP after 5 months ( Fig. 4) . HSCs with the highest H2B-GFP content (approximately top 20%) were capable of lympho-myeloid hematopoiesis that improved with time ( Fig. 4 , upper right panel). In contrast, HSCs with reduced H2B-GFP content had less repopulation potential ( Fig. 4 , upper middle panel), and HSCs that had entirely lost H2B-GFP had markedly reduced repopulation potential ( Fig. 4, upper left panel) . These findings were confirmed in secondary transplants (Fig. 4, bottom panels) . Notably, loss of H2B-GFP retention correlated with the acquisition of CD34 (Supplementary Fig. 9b online), which is absent on mouse long-term HSCs 14 , and H2B-GFP retention correlated with high expression of EPCR ( Supplementary  Fig. 9c) , an alternative marker for HSCs 17 . Detection of either of these markers in addition to the L -K + S + CD48 -CD150 + combination allowed for enhanced identification of label-retaining cells ( Supplementary  Fig. 10 online) , raising the possibility that more complex marker combinations might be used to develop even more refined HSC identification protocols in the future. Our results suggest that H2B-GFP label retention in combination with markers that are highly selective for HSCs correlate with longterm repopulation potential. However, we cannot exclude the possibility that the observed heterogeneity in proliferation and repopulation potential among L -K + S + CD48 -CD150 + -defined HSCs arose from a mixture of stem and progenitor cells. The frequency of functional long-term repopulating HSCs among L -K + S + CD48 -CD150 + cells diminishes as mice age; in 6-week-old mice 1 in 2 of these cells 4 and in 22-week-old mice only 1 in 7 of L -K + S + CD48 -CD150 + cells repopulate long term 29 . It is unclear whether this decrease in frequency of long-term repopulating cells is due to expansion of progenitors over the long period of observation, we show curves for 4-8 divisions in Figure 3) ; and (iii) that HSCs in the bone marrow are maintained in a steady state. Given a uniform HSC turnover rate of 6% per day 3 , our model predicts that all HSCs will become H2B-GFP-negative less than 300 d after the pulse (Fig. 3a) . Although this model roughly fits the experimental data for the first 100-200 d, it sharply underestimates the detected proportions of H2B-GFP-positive cells at later time points, suggesting a lower turnover rate. Models obtained with a uniform division rate of 2% per day (Fig. 3b) , which is lower than any rate previously estimated with BrdU incorporation (6% per day 3 , 7.8% per day 19 ~3% per day 27, 28 ), fit the observed proportions better at later time points but underestimate H2B-GFP loss at early time points. Thus, our data cannot be easily reconciled with the conventional view that all HSCs proliferate at similar rates.
Next, we generated models assuming a larger population (~80%) cycling faster and a smaller population (~20%) cycling more slowly. Such two-component models appropriately predicted the observed proportions of GFP-positive cells over time (Fig. 3c,d) and showed significantly (P = 0.013) better fit to the experimental data (Fig. 3d) . Depending on whether loss of detectable GFP was assumed to occur after 4 or 8 divisions, these models fit the data with a larger population cycling at 5.3-11.1% per day and a slower population cycling at 0.8-1.8% per day (Fig. 3d) . It is likely that the actual proliferation rates of HSCs are even lower than our model suggests because we cannot estimate the losses of H2B-GFP resulting from protein turnover during the long observation period. Nevertheless, our findings are compatible with the conclusion from long-term (180 d) BrdU administration 19 that all HSCs do eventually divide.
To test predictions of our model and to determine whether the existence of different turnover rates among L -K + S + CD48 -CD150 + -defined sharing this phenotype or loss of long-term repopulation potential (and concomitant acquisition of CD34, Supplementary Fig. 9b ) among genuine HSCs. Therefore, we cannot unambiguously conclude that the proliferation history of HSCs predicts their long-term repopulation potential, as has been observed in the setting of transplantation 30 .
In conclusion, the H2B-GFP labeling system presented here provides a useful tool for the study of HSC turnover that compares favorably to BrdU. Its critical advantages are the brightness of the label, which permits monitoring of more divisions over a longer time period, the ability to label virtually all HSCs independent of their cycling status and the possibility to recover viable cells after analysis for functional testing.
METHODS

Mice.
TetOP-H2B-GFP mice were generated following our previously described method 31 . R26::rtTA mice and Gfi-1KO mice were previously published 32, 33 . p21 Cip1/Waf1KO mice (003263, B6;129Sv), C57bl/6 and B6.SJL (002014) mice were purchased from Jackson Laboratories. Mice were cared for according to the guidelines and supervision of the Massachusetts General Hospital Subcommittee on Animal Research (SRAC). For transgene expression, doxycycline (Sigma D9891, 2 mg/ml, supplemented with sucrose at 10 mg/ml) was added to drinking water for 6 weeks (4-to 8-week-old mice at the beginning of treatment).
Flowcytometric analysis and cell sorting.
A modified fluorescence-activated cell sorting (FACS) ARIA flow cytometer with five lasers (UV 300 nm, violet 405 nm, blue 488 nm, green 532 nm, red 633 nm) was used for analysis and sorting of HSCs. Immunostaining was carried out as described 25, 34 . Antibody conjugates were obtained from BD Biosciences or eBioscience, unless otherwise indicated. HSC stains: lineage markers CD4 (RM4-5), CD8 (53-6), CD3ε (145-2C11), TCRβ (H54-597), B220 (RA3-6B2), Gr1 (RB6-8C5), Mac-1 (M1/70), Ter119 (all Cy-Chrome or PE-Cy5), CD117 (c-Kit, 2B8, APC, Alexa 750), CD135 (Flt3, A2F10, PE), Sca-1 (E13-161, FITC, PE), Sca-1 (D7, Pacific Blue, H2B-GFP retention of L -K + S + CD48 -CD150 + HSCs predicts function. One hundred L -K + S + CD48 -CD150 + -defined HSCs from H2B-GFP transgenic mice (CD45.2) were transplanted into irradiated recipients (CD45.1) together with a small number of support bone marrow cells (CD45.1) to ensure survival. Three upper plots show the proportions of donor-derived B cells and granulocytes in groups of recipient mice (primary recipients; H2B-GFP neg , left, n = 4; H2B-GFP int , middle, n = 3; H2B-GFP hi , right, n = 2). Note that cells with the same immuno-phenotype, but distinct H2B-GFP content, possess different repopulation potential. Bottom panels show donor-derived hematopoiesis in recipients of secondary transplants (performed 7 weeks after the primary transplant) from either the H2B-GFP neg group (left, n = 5, donor was the most highly reconstituted primary transplant recipient) or the H2B-GFP hi group (right, n = 5 monoclonal antibodies. Subsequently, cells were stained with appropriate fluorchrome-conjugated HSC markers, including lineage cocktail. Residual biotinylated antibodies were detected with streptavidin-PE-Cy5 and cells were subjected to two rounds of FACS-sorting to achieve virtual purity.
Bone marrow transplantation. Bone marrow transplantations were performed by intravenous injection of sorted donor cells (C57/bl6, CD45.2) and 2 × 10 5 competitor bone marrow (2 × 10 5 cells (B6.SJL) into recipients (B6. SJL, CD45.1) that had received 1,200 cGy of radiation as a split dose as previously described 25, 34 .
In vitro culture of single HSCs and quantification of fluorescence. Rosa26-rtTA/tetO-H2BGFP L -S + K + CD48 -CD150 + HSCs were single cell sorted into Terasaki plates (Nunc 60 MicroWell) and cultured in 5% CO 2 at 37 °C in 10 µl of StemSpan serum-free expansion medium (StemCell Technologies) supplemented with 50 ng/ml mouse stem cell factor 20 ng/ml human thrombopoietin and 10 ng/ml mouse interleukin-3 (R&D Systems). Cells were monitored every day for divisions and fresh medium containing cytokines was added every 2 d. Dividing cells were imaged using an inverted Leica DMI4000B fluorescence microscope before and after they had undergone divisions. Images were quantified using ImageJ software (Research Services Branch, National Institutes of Health), and values were recorded as pixel intensity.
Mathematical modeling. A model for H2B-GFP loss in a stem cell population continuously turning over and maintained at steady state levels was generated by conceptualizing the data underlying Figure 3 as a variation on the familiar Kaplan-Meier (KM) curve for survival analysis 35 . In the classical approach to statistical modeling of event-time data, data on times (T) elapsed from a common origin to an event of interest are collected, and the KM curve relates time t elapsed on the x axis to S(t) = Pr(T > t) on the y axis. At the origin, S(t) = 1, and as t approaches infinity, S(t) approaches 0. The data presented in Figure 3 fit this framework if we consider the time to event to be the time elapsed during the succession of divisions leading to loss of H2B-GFP positivity. However, instead of modeling cell lifetimes in the KM framework, we are modeling the duration of time from onset of chase to the event of the K th division, where K denotes the number of divisions for which H2B-GFP can be detected above an arbitrary threshold. If the cell lifetimes are independently and identically exponentially distributed with mean 1/λ, then, owing to the reproductivity property of the exponential model 36 GFP-positivity times will have mean K/λ. We can transform a model for the observed GFP-positivity times (the sum of K lifetimes) to a model for cell lifetimes and thus to an estimate of the cell turnover rate under the assumptions of a fixed K and a common cell lifetime distribution. Formally, H2B-GFP content in stem cells are measured as proportions π ∼ of cells gating positive for GFP after various numbers τ ∼ of days of chase (see Fig. 1c , π ∼ are plotted as open circles in Fig. 3 ). We assume that each stem cell's lifetime (time elapsed from division of its ancestor to point of its own division) follows an exponential probability distribution, specified by a scalar rate parameter to be denoted λ (given in Fig. 3 as % cells cycling per day), and that at the end of the lifetime, the cell is replaced by a daughter bearing approximately half the mother's GFP content. We also assume that each cell in a lineage is GFP positive up to the K th division, at which point all cells in the future of the lineage are GFP-negative. This threshold division count K is common to all cells. Under these assumptions, with a generational origin determined by experiment for all lineages, the probability that cells at time origin+t have undergone fewer than K divisions is: π(τ; λ, K) = Σ m=0 K-0 e -λτ (λτ) m m! The foregoing homogeneous model is extended with a two-component model in which one subpopulation of stem cells divides at rate λ 1 and another divides at rate λ 2 . If p ∈ (0,1) is the proportion of cells in the first subpopulation, the extended model is π*(τ; p; λ 1 ; λ 2 , K) = pπ(τ; λ 1 ; K) + (1 -p)π(τ; λ 2 , K)
For various fixed values of K, parameters of models π and are estimated using non-linear least squares on the basis of data values π * and τ ∼ 37 .
